Chemoimmunoconjugates with the monoclonal antibody 138H11 for targeting the cytotoxic prodrug calicheamicin θ to renal cell carcinomas

Tumor Targeting

Volumn 4, Issue 4, 1999, Pages 271-277

  Schmidt, C S ^a   Wrasidlo, W ^a   Scherberich, J E ^a   Gaedicke, G ^a   Fischer, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Calicheamicin; Chemoimmunoconjugate; Monoclonal antibody; Prodrug; Renal cell carcinoma

Indexed keywords

CALICHEAMICIN; CALICHEAMICIN THETA; GAMMA GLUTAMYLTRANSFERASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 138H11; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG FORMULATION; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL;

EID: 0033499797     PISSN: 13518488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)